Psychiatry / Neuropharmacology

Research in psychiatry concerns conditions such as addiction, depression, psychosis, schizophrenia, anxiety, personality disorders and suicidal behaviour.

MR brain images in a row.

Clinical scientists strive to improve diagnosis and treatment of these conditions based on improved phenotypic characterization, using for example neuropsychology and brain imaging by positron emission tomography (PET).

Genetic markers in clinical cohorts are analyzed with regard to treatment response and long-term outcome. Basic scientists develop and use animal models to elucidate fundamental mechanisms contributing to psychiatric disease and to design new treatment strategies.

Group leaders and research areas

Anne H. Berman, Treatment of alcohol and drug problems

Marie Carlén, Brain networks and psychiatric disorders

Aila Collins, Psychology, women's health

Pia Enebrink, Child and adolescent psychiatry

Göran Engberg, Electrophysiological neuropharmacology

Sophie Erhardt, Neuropsychopharmacology

Lars Fardel, Positron emission tomography in the human brain

Gilberto Fisone, Molecular neuropharmacology

Lena Flyckt, Clinical characteristics

Johan Franck, Treatment of addictive disorders

Kjell Fuxe, Molecular neuropharmacology

Clara Gumpert, Mental disorder and antisocial development

Petter Gustavsson, Differential psychology and health

Christer Halldin, Positron emission tomography in the human brain

Anders Helander, Alcohol biomarkers

Erik Jönsson, Psychiatric genetics

Håkan Karlsso, nMolecular genetic studies of schizophrenia

Marianne Kristiansson, Forensic neuroscience

Mikael Landén, Biological psychiatry

Håkan Leifman, Prevention of alcohol and drug addiction

Nils Lindefors, Psychiatric diagnosis and treatment

Maria Lindskog, Synaptic transmission and mood disorders

Niklas Långström, Psychiatric epidemiology

Bo Melin, Cognitive and emotion in relation to health

Mussie Msghina, fMRI

Ullakarin Nyberg, Suicide, loss and consequences

Tom Palmstierna, Social and forensic psychiatry

Christian Rück, Anxiety, obsessive-compulsive disorder and genetics

Bo Runeson, Epidemiology of affective disorder and suicide

Eva Serlachius, Treatment development – child and adolescent psychiatry

Sharon Stone-Elander, Cognitive neurophysiology – medical radiochemistry

Per Svenningsson, Neuropharmacology – movement disorders

Torgny Svensson, Neuropsychopharmacology

Lars Terenius, Experimental addiction research

Lisa Thorell, Cognitive processes and ADHD

Jari Tiihonen, Psychopharmacology, schizophrenia, substance abuse

Dag Årsland, Translational geriatric neuropsychiatry

Sven Ove Ögren, Cognitive mechanisms underlying complex behaviour